Brightsurf Science News and Current Science News Events
 

Prostate Cancer News | Prostate Cancer Current Events
Page 9 of 97 | 2404 Results
Previous0405060708091011121314   Next   
Sort By: Page Views | Date
Smoking and Obesity May Increase the Risk of Erectile Dysfunction
A prospective study by researchers from the Harvard School of Public Health (HSPH) has found that obesity and smoking are strongly associated with a greater risk of erectile dysfunction (ED).   view more (2006-06-28)

Outcome of prostate cancer surgery depends on the experience of the surgeon
According to a new study published online today in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.   view more (2007-07-25)

Cancer-resistant mouse discovered
A mouse resistant to cancer, even highly-aggressive types, has been created by researchers at the University of Kentucky.   view more (2007-11-27)

How advanced prostate cancer becomes resistant to androgen-deprivation therapy
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy.   view more (2008-06-02)

Vitamin D, NSAIDS provide double whammy against prostate cancer, Stanford study finds
The growth of prostate cancer cells can be halted by combining a form of vitamin D, available only by prescription, with low doses of an over-the-counter painkiller, researchers at the Stanford University School of Medicine have found.   view more (2005-09-02)

Early estrogen exposure leads to later prostate cancer risk
A study in the June 1 issue of Cancer Research presents the first evidence that exposure to low doses of environmental estrogens during development of the prostate gland in the male fetus may result in a predisposition to prostate cancer later in life.   view more (2006-06-01)

Some screening tests should not be advocated
Certain screening tests for cancer are of unproved value and should not be advocated, argues a senior doctor in this week's BMJ.   view more (2004-02-05)

New research may show why some prostate cancer recurs after treatment
Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth.   view more (2007-10-12)

Lycopene slows human prostate tumour growth in mice and combining it with vitamin E is even better
A study by Dutch and German researchers has provided evidence that lycopene may be able to inhibit the growth of prostate tumours and that its effect may be enhanced if it is combined with vitamin E.   view more (2004-09-28)

Novel enzyme offers new look at male hormone regulation
For the second time in less than a year, University of North Carolina at Chapel Hill scientists have purified a novel protein and have shown it can alter gene activity by reversing a molecular modification previously thought permanent.   view more (2006-05-08)

Research shows certain metabolites responsible for initiating breast and prostate cancer
Cancer researchers have discovered that metabolites of natural estrogens can react with deoxyribonucleic acid (DNA) to cause specific damage that initiates the series of events leading to breast, prostate and other human cancers.   view more (2006-03-29)

OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic... view more (2007-06-04)

Octogenarians are not too old for cancer surgery
Mayo Clinic Cancer Center researchers have found that a radical prostatectomy can be a viable option for select octogenarian patients. The findings, which run counter the conventional practice of generally avoiding surgeries for individuals over 80 years old solely based on age, are available today... view more (2006-11-28)

Study finds gene linked to aggressive prostate cancer
Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer.   view more (2007-12-12)

Major genetic risk factor found for prostate cancer
Harvard Medical School researchers have identified a DNA segment on chromosome 8 that is a major risk factor for prostate cancer, especially in African American men.   view more (2006-08-22)

UI Researchers Studying Novel Therapy For Prostate Cancer
A team of University of Iowa Health Care researchers has launched an important clinical trial of a novel therapeutic that may eventually lead to new treatments for men diagnosed with prostate cancer.   view more (2006-10-16)

Generic prostate drug helps find high-risk cancers early
Men now have another good reason to consider taking finasteride, a well-known generic drug that shrinks an enlarged prostate and reduces the risk of getting prostate cancer by 25 percent.   view more (2007-09-12)

Low education predicts lower quality of life for prostate cancer patients
Among men who have received similar treatments for prostate cancer, those with less education -- particularly those who did not graduate from high school -- experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by... view more (2007-04-13)

Flaxseed stunts the growth of prostate tumors
Flaxseed, an edible seed that is rich in omega 3-fatty acids and fiber-related compounds known as lignans, is effective in halting prostate tumor growth.   view more (2007-06-04)

Prostate Cancer : Signature of a partnership agreement between Beaufour Ipsen and UroGene
The pharmaceutical group Beaufour Ipsen and the biopharmaceutical company UroGene have just signed a partnership agreement for the functional and clinical evaluation of a class of molecules in the field of prostate cancer. UroGene will be contributing its molecular genomic know-how, its biological... view more (2002-07-17)

Drug attacks prostate cancer in mouse model by destroying its blood supply
A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply.   view more (2006-06-07)

Phase II trials of second-generation antisense cancer drug planned following successful early study
Geneva, Switzerland: Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.   view more (2004-09-26)

Why a common treatment for prostate cancer ultimately fails
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.   view more (2008-08-22)

Prostate cancer screening creates new dilemma for men, says professor
Between 70 and 80 per cent of prostate cancer was now being diagnosed at a stage where it may be curable, a press conference at ECCO 11 - The European Cancer Conference in Lisbon heard today (Wednesday, October 23, 2001). "We used to have a situation in which one of every two patients... view more (2001-10-23)

University of Leicester research reveals rice bran could reduce risk of intestinal cancer
A study by biomedical scientists at the University of Leicester has revealed for the first time that rice bran could reduce the risk of intestinal cancer.   view more (2007-03-27)
Page 9 of 97 | 2404 Results
Previous0405060708091011121314   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com